These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delaware
|
.
|
13-3115216
|
|
(State
of incorporation)
|
|
(IRS
Employer Identification Number)
|
|
|
|
|
|
3555
Veterans Memorial Highway, Suite C, Ronkonkoma, New
York
|
|
11779
|
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
|
Title
of each class
|
Trading
Symbol(s)
|
Name of
each exchange on which registered
|
|
Common
Stock
|
LAKE
|
NASDAQ
|
|
Large accelerated filer ☐
|
Accelerated filer ☒
|
|
Non-accelerated
filer ☐
|
Smaller reporting company ☒
|
|
Emerging
growth company ☐
|
|
|
Class
|
Outstanding at
December 6, 2019
|
|
Common
Stock, $0.01 par value per share
|
8,006,829
shares
|
|
Item
1.
|
Financial
Statements (Unaudited)
|
Page
|
|
|
|
|
|
|
Introduction
|
3
|
|
|
|
|
|
|
Condensed
Consolidated Statements of Operations Three and Nine Months Ended
October 31, 2019 and 2018
|
5
|
|
|
|
|
|
|
Condensed
Consolidated Statements of Comprehensive Income Three and Nine
Months Ended October 31, 2019 and 2018
|
6
|
|
|
|
|
|
|
Condensed Consolidated Balance Sheets
October 31, 2019
and January 31, 2019
|
7
|
|
|
|
|
|
|
Condensed
Consolidated Statements of Stockholders’ Equity Three and
Nine Months Ended October 31, 2019 and 2018
|
8
|
|
|
|
|
|
|
Condensed
Consolidated Statements of Cash Flows Nine Months Ended October 31,
2019 and 2018
|
9
|
|
|
|
|
|
|
Notes
to Condensed Consolidated Financial Statements
|
10
|
|
|
|
|
|
Item
2.
|
Management's
Discussion and Analysis of Financial Condition and Results of
Operations
|
29
|
|
|
|
|
|
Item
3.
|
Quantitative
and Qualitative Disclosures About Market Risk
|
35
|
|
|
|
|
|
Item
4.
|
Controls
and Procedures
|
35
|
|
|
|
|
|
|
PART II - OTHER INFORMATION:
|
|
|
|
|
|
|
Item
6.
|
Exhibits
|
36
|
|
|
|
|
|
|
Signature
Pages
|
37
|
|
|
Three Months
Ended
October
31,
|
Nine Months
Ended
October
31,
|
||
|
|
2019
|
2018
|
2019
|
2018
|
|
Net
sales
|
$
27,464
|
$
24,009
|
$
79,620
|
$
73,970
|
|
Cost of goods
sold
|
18,166
|
15,691
|
52,349
|
46,995
|
|
Gross
profit
|
9,298
|
8,318
|
27,271
|
26,975
|
|
Operating
expenses
|
7,464
|
7,305
|
23,114
|
21,898
|
|
Operating
profit
|
1,834
|
1,013
|
4,157
|
5,077
|
|
Other income
(expense), net
|
(9
)
|
7
|
(33
)
|
36
|
|
Interest
expense
|
(26
)
|
(25
)
|
(98
)
|
(93
)
|
|
Income before
taxes
|
1,799
|
995
|
4,026
|
5,020
|
|
Income tax
expense
|
653
|
494
|
1,950
|
1,634
|
|
Net
income
|
$
1,146
|
$
501
|
$
2,076
|
$
3,386
|
|
Net income per
common share:
|
|
|
|
|
|
Basic
|
$
0.14
|
$
0.06
|
$
0.26
|
$
0.42
|
|
Diluted
|
$
0.14
|
$
0.06
|
$
0.26
|
$
0.41
|
|
Weighted average
common shares outstanding:
|
|
|
|
|
|
Basic
|
8,004,640
|
8,119,488
|
8,013,383
|
8,117,307
|
|
Diluted
|
8,035,929
|
8,186,130
|
8,044,159
|
8,174,560
|
|
|
|
|
|
|
|
|
Three Months
Ended
October
31,
|
Nine Months
Ended
October
31,
|
||
|
|
2019
|
2018
|
2019
|
2018
|
|
|
|
|
|
|
|
Net
income
|
$
1,146
|
$
501
|
$
2,076
|
$
3,386
|
|
Other comprehensive
loss:
|
|
|
|
|
|
Foreign currency
translation adjustments
|
(177
)
|
(235
)
|
(402
)
|
(860
)
|
|
Comprehensive
income
|
$
969
|
$
266
|
$
1,674
|
$
2,526
|
|
ASSETS
|
October
31,
|
January
31,
|
|
|
2019
|
2019
|
|
Current
assets
|
|
|
|
Cash and cash
equivalents
|
$
9,473
|
$
12,831
|
|
Accounts
receivable, net of allowance for doubtful accounts of $602 and $434
at October 31, 2019 and January 31, 2019, respectively
|
17,413
|
16,477
|
|
Inventories
|
47,797
|
42,365
|
|
Prepaid VAT and
other taxes
|
1,316
|
1,478
|
|
Other current
assets
|
2,622
|
2,319
|
|
Total current
assets
|
78,621
|
75,470
|
|
Property and
equipment, net
|
10,233
|
10,781
|
|
Operating leases
right-of-use assets
|
2,482
|
-----
|
|
Deferred tax
assets
|
6,600
|
7,267
|
|
Prepaid VAT and
other taxes
|
176
|
176
|
|
Other
assets
|
121
|
158
|
|
Goodwill
|
871
|
871
|
|
Total
assets
|
$
99,104
|
$
94,723
|
|
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
|
|
|
Current
liabilities
|
|
|
|
Accounts
payable
|
$
6,246
|
$
6,214
|
|
Accrued
compensation and benefits
|
1,699
|
1,137
|
|
Other accrued
expenses
|
3,227
|
2,825
|
|
Current maturity of
long-term debt
|
1,194
|
158
|
|
Current portion of
operating lease liabilities
|
254
|
-----
|
|
Total current
liabilities
|
12,620
|
10,334
|
|
Long-term
portion of debt
|
-----
|
1,161
|
|
Long-term
portion of operating lease liabilities
|
2,243
|
-----
|
|
Total noncurrent
liabilities
|
2,243
|
1,161
|
|
Total
liabilities
|
14,863
|
11,495
|
|
Commitments and
contingencies
|
|
|
|
Stockholders’
equity
|
|
|
|
Preferred stock,
$0.01 par; authorized 1,500,000 shares (none issued)
|
-----
|
-----
|
|
Common stock, $0.01
par; authorized 20,000,000 shares
issued 8,478,118
and 8,475,929; outstanding 8,006,829 and 8,013,840 shares at
October 31, 2019 and January 31, 2019, respectively
|
85
|
85
|
|
Treasury stock, at
cost; 471,289 and 462,089 shares at October 31, 2019 and January
31, 2019, respectively
|
(4,614
)
|
(4,517
)
|
|
Additional paid-in
capital
|
75,048
|
75,612
|
|
Retained
earnings
|
16,376
|
14,300
|
|
Accumulated other
comprehensive loss
|
(2,654
)
|
(2,252
)
|
|
Total stockholders'
equity
|
84,241
|
83,228
|
|
Total liabilities
and stockholders' equity
|
$
99,104
|
$
94,723
|
|
|
Common
Stock
|
Treasury
Stock
|
Additional
Paid-in
|
Retained
|
Accumulated
Other Comprehensive
|
|
||
|
|
Shares
|
Amount
|
Shares
|
Amount
|
Capital
|
Earnings
|
Loss
|
Total
|
|
|
|
($000’s)
|
|
($000’s)
|
($000’s)
|
($000’s)
|
($000’s)
|
($000’s)
|
|
Balance, January 31,
2018
|
8,472,640
|
$
85
|
(356,441
)
|
$
(3,352
)
|
$
74,917
|
$
12,841
|
$
(1,651
)
|
$
82,840
|
|
Net income
|
-----
|
-----
|
-----
|
-----
|
-----
|
3,386
|
-----
|
3,386
|
|
Other comprehensive
loss
|
-----
|
-----
|
-----
|
-----
|
-----
|
-----
|
(860
)
|
(860
)
|
|
Stock-based
compensation:
|
|
|
|
|
|
|
|
|
|
Restricted Stock Plan
|
3,289
|
-----
|
-----
|
-----
|
467
|
-----
|
-----
|
467
|
|
Balance, October 31,
2018
|
8,475,929
|
$
85
|
(356,441
)
|
$
(3,352
)
|
$
75,384
|
$
16,227
|
$
(2,511
)
|
$
85,833
|
|
|
|
|
|
|
|
|
|
|
|
Balance, July 31,
2018
|
8,472,640
|
$
85
|
(356,441
)
|
$
(3,352
)
|
$
75,221
|
$
15,726
|
$
(2,275
)
|
$
85,405
|
|
Net income
|
-----
|
-----
|
-----
|
-----
|
-----
|
501
|
-----
|
501
|
|
Other comprehensive
loss
|
-----
|
-----
|
-----
|
-----
|
-----
|
-----
|
(236
)
|
(236
)
|
|
Stock-based
compensation:
|
|
|
|
|
|
|
|
|
|
Restricted Stock
Plan
|
3,289
|
-----
|
-----
|
-----
|
163
|
-----
|
-----
|
163
|
|
Balance, October 31,
2018
|
8,475,929
|
$
85
|
(356,441
)
|
$
(3,352
)
|
$
75,384
|
$
16,227
|
$
(2,511
)
|
$
85,833
|
|
|
|
|
|
|
|
|
|
|
|
Balance, January 31,
2019
|
8,475,929
|
$
85
|
(462,089
)
|
$
(4,517
)
|
$
75,612
|
$
14,300
|
$
(2,252
)
|
$
83,228
|
|
Net income
|
-----
|
-----
|
-----
|
-----
|
-----
|
2,076
|
-----
|
2,076
|
|
Other comprehensive
loss
|
-----
|
-----
|
-----
|
-----
|
-----
|
-----
|
(402
)
|
(402
)
|
|
Stock-based
compensation:
|
|
|
|
|
|
|
|
|
|
Restricted Stock
Plan
|
2,189
|
-----
|
-----
|
-----
|
(559
)
|
-----
|
-----
|
(559
)
|
|
Returned of shares in lieu of
payroll tax withholding
|
-----
|
-----
|
-----
|
-----
|
(5
)
|
-----
|
-----
|
(5
)
|
|
Treasury stock purchased; inclusive
of commissions
|
-----
|
-----
|
(9,200
)
|
(97
)
|
-----
|
-----
|
-----
|
(97
)
|
|
Balance, October 31,
2019
|
8,478,118
|
$
85
|
(471,289
)
|
$
(4,614
)
|
$
75,048
|
$
16,376
|
$
(2,654
)
|
$
84,241
|
|
Balance, July 31,
2019
|
8,475,929
|
$
85
|
(471,289
)
|
$
(4,614
)
|
$
75,361
|
$
15,230
|
$
(2,477
)
|
$
83,585
|
|
Net income
|
-----
|
-----
|
-----
|
-----
|
-----
|
1,146
|
-----
|
1,146
|
|
Other comprehensive
loss
|
-----
|
-----
|
-----
|
-----
|
-----
|
-----
|
(177
)
|
(177
)
|
|
Stock-based
compensation:
|
|
|
|
|
|
|
|
|
|
Restricted Stock Plan and stock
options
|
2,189
|
-----
|
-----
|
-----
|
(308
)
|
-----
|
-----
|
(308
)
|
|
Returned of shares in lieu of
payroll tax withholding
|
-----
|
-----
|
-----
|
-----
|
(5
)
|
-----
|
-----
|
(5
)
|
|
Balance, October 31,
2019
|
8,478,118
|
$
85
|
(471,289
)
|
$
(4,614
)
|
$
75,048
|
$
16,376
|
$
(2,654
)
|
$
84,241
|
|
|
Nine Months
Ended
October
31,
|
|
|
|
2019
|
2018
|
|
Cash flows from
operating activities:
|
|
|
|
Net
income
|
$
2,076
|
$
3,386
|
|
Adjustments to
reconcile net income to net cash used in operating
activities
|
|
|
|
Provision for of
doubtful accounts
|
168
|
76
|
|
Deferred income
taxes
|
667
|
352
|
|
Depreciation and
amortization
|
1,267
|
642
|
|
Stock based and
restricted stock compensation
|
(583
)
|
491
|
|
Loss on disposal of
property and equipment
|
(2
)
|
14
|
|
Non-cash operating
lease expense
|
797
|
-----
|
|
(Increase) decrease
in operating assets
|
|
|
|
Accounts
receivable
|
(1,257
)
|
(2,655
)
|
|
Inventories
|
(5,584
)
|
(4,121
)
|
|
Prepaid VAT and
other taxes
|
162
|
148
|
|
Other current
assets
|
(355
)
|
(1,284
)
|
|
Increase (decrease)
in operating liabilities
|
|
|
|
Accounts
payable
|
67
|
1,019
|
|
Accrued expenses
and other liabilities
|
517
|
265
|
|
Operating lease
liabilities
|
(783
)
|
-----
|
|
Net cash used in
operating activities
|
(2,843
)
|
(1,667
)
|
|
Cash flows used in
investing activities:
|
|
|
|
Purchases of
property and equipment
|
(689
)
|
(2,227
)
|
|
Cash flows from
financing activities:
|
|
|
|
Loan repayments,
short-term
|
(124
)
|
(207
)
|
|
Loan borrowings,
short-term
|
-----
|
208
|
|
Loan repayments,
long-term
|
-----
|
(118
)
|
|
UK borrowings
(repayments) under line of credit facility, net
|
491
|
(11
)
|
|
Purchase
of Treasury Stock under stock repurchase program
|
(97
)
|
-----
|
|
Shares
returned to pay employee taxes under restricted stock
program
|
(5
)
|
-----
|
|
Net cash provided
by (used in) financing activities
|
265
|
(128
)
|
|
Effect of exchange
rate changes on cash and cash equivalents
|
(91
)
|
(106
)
|
|
Net decrease in
cash and cash equivalents
|
(3,358
)
|
(4,128
)
|
|
Cash and cash
equivalents at beginning of period
|
12,831
|
15,788
|
|
Cash and cash
equivalents at end of period
|
$
9,473
|
$
11,660
|
|
|
|
|
|
Supplemental
disclosure of cash flow information:
|
|
|
|
Cash paid for
interest
|
$
98
|
$
93
|
|
Cash paid for
taxes
|
$
1,202
|
$
1,326
|
|
|
|
|
|
Noncash investing
and financing activities
|
|
|
|
Leased assets
obtained in exchange for operating lease liabilities
|
$
3,218
|
$
-----
|
|
|
Three Months Ended
October
31,
(in millions of dollars)
|
Nine Months Ended
October 31,
(in millions of dollars)
|
||
|
|
2019
|
2018
|
2019
|
2018
|
|
External
Sales by region:
|
|
|
|
|
|
USA
|
$
14.16
|
$
11.82
|
$
41.47
|
$
37.54
|
|
Other
foreign
|
0.91
|
0.72
|
2.61
|
2.30
|
|
Europe
(UK)
|
2.38
|
2.22
|
7.24
|
7.35
|
|
Mexico
|
0.88
|
0.77
|
2.08
|
2.70
|
|
Asia
|
4.62
|
4.80
|
12.49
|
12.79
|
|
Canada
|
2.60
|
2.08
|
7.47
|
6.38
|
|
Latin
America
|
1.91
|
1.60
|
6.26
|
4.91
|
|
Consolidated
external sales
|
$
27.46
|
$
24.01
|
$
79.62
|
$
73.97
|
|
|
Three Months Ended
October 31
,
(in millions of dollars)
|
Nine Months Ended
October 31,
(in millions of dollars)
|
||
|
|
2019
|
2018
|
2019
|
2018
|
|
External
Sales by product lines:
|
|
|
|
|
|
Disposables
|
$
12.52
|
$
12.74
|
$
39.19
|
$
40.88
|
|
Chemical
|
5.68
|
4.74
|
16.30
|
12.42
|
|
Fire
|
2.81
|
1.02
|
6.64
|
3.57
|
|
Gloves
|
0.74
|
0.77
|
2.33
|
2.30
|
|
Hi-Vis
|
2.20
|
1.83
|
6.04
|
5.46
|
|
Wovens
|
3.51
|
2.91
|
9.12
|
9.34
|
|
Consolidated
external sales
|
$
27.46
|
$
24.01
|
$
79.62
|
$
73.97
|
|
|
October
31,
2019
|
January
31,
2019
|
|
|
|
|
|
Raw
materials
|
$
17,230
|
$
14,986
|
|
Work-in-process
|
441
|
987
|
|
Finished
goods
|
$
30,126
|
26,392
|
|
|
$
47,797
|
$
42,365
|
|
Leases
(000’s)
|
Classification
|
October 31,
2019
|
|
|
|
|
|
Assets
|
|
|
|
Operating lease
assets
|
Operating lease
right-of-use assets
|
$
2,482
|
|
|
|
|
|
Liabilities
|
|
|
|
Current
|
|
|
|
Operating
|
Current portion of
operating lease liabilities
|
$
254
|
|
Noncurrent
|
|
|
|
Operating
|
Long-term portion
of operating lease liabilities
|
2,243
|
|
Total Lease
Obligations
|
|
$
2,497
|
|
|
Classification
|
Three Months Ended
October 31, 2019 |
Nine Months Ended
October 31, 2019 |
|
Operating lease
cost
|
Cost of goods
sold
|
$
53
|
$
342
|
|
|
Operating
expenses
|
$
269
|
$
507
|
|
Short-term lease
cost
|
|
$
444
|
$
572
|
|
Year ending
January 31,
|
Operating
Leases
(a)
|
|
Remainder of fiscal
year 2020
|
254
|
|
2021
|
955
|
|
2022
|
802
|
|
2023
|
686
|
|
2024
|
23
|
|
Thereafter
|
81
|
|
Total lease
payments
|
2,801
|
|
Less:
Interest
|
304
|
|
Present value of
lease liability
|
$
2,497
|
|
|
October
31,
2019
|
|
Weighted-average
remaining lease term (years)
|
|
|
Operating
leases
|
2.72
|
|
|
|
|
Weighted-average
discount rate
|
|
|
Operating
leases
|
5.83
%
|
|
Cash paid for
amounts included in the measurement of lease
liabilities;
|
Nine Months
Ended
October
31,
2019
|
|
Operating cash
flows from operating leases
|
$
783
|
|
Leased assets
obtained in exchange for new operating lease
liabilities
|
$
3,218
|
|
Year ended
January 31,
|
Gross
rental
|
|
|
|
|
2019
|
$
1,022
|
|
2018
|
$
841
|
|
Year
ending
January
31
|
|
|
2020
|
$
761
|
|
2021
|
447
|
|
2022
|
435
|
|
2023
|
314
|
|
2024
|
8
|
|
and
thereafter
|
9
|
|
Total
|
$
1,974
|
|
|
Short-Term
|
Long-term
|
Current
Maturity of
Long-term
|
|||
|
|
October
31,
|
January
31,
|
October
31,
|
January
31,
|
October
31,
|
January
31,
|
|
|
2019
|
2019
|
2019
|
2019
|
2019
|
2019
|
|
|
|
|
|
|
|
|
|
USA
|
$
1,194
|
$
-----
|
$
-----
|
$
1,161
|
$
-----
|
$
158
|
|
UK
|
$
494
|
-----
|
-----
|
-----
|
-----
|
-----
|
|
Totals
|
$
1,688
|
$
-----
|
$
-----
|
$
1,161
|
$
-----
|
$
158
|
|
|
Total
|
1
Year
or
less
|
2
Years
|
3
Years
|
4
Years
|
5
Years
|
After 5
Years
|
|
|
|
|
|
|
|
|
|
|
Borrowings in
USA
|
$
1,194
|
$
1,194
|
$
-----
|
$
-----
|
$
-----
|
$
-----
|
$
-----
|
|
Borrowing in the
UK
|
494
|
494
|
-----
|
-----
|
-----
|
-----
|
-----
|
|
Total
|
$
1,688
|
$
1,688
|
$
-----
|
$
-----
|
$
-----
|
$
-----
|
$
-----
|
|
|
Number of shares
awarded total
|
|||
|
|
Minimum
|
Target
|
Maximum
|
Cap
|
|
Employees
|
35,863
|
53,796
|
71,728
|
86,125
|
|
Non-employee
Directors
|
14,414
|
21,622
|
28,829
|
34,595
|
|
Total
|
50,277
|
75,418
|
100,557
|
120,720
|
|
|
Value at grant
date (numbers below are rounded to the nearest $100)
|
|||
|
|
Minimum
|
Target
|
Maximum
|
Cap
|
|
Employees
|
$
497,600
|
$
746,400
|
$
995,200
|
$
1,194,900
|
|
Non-employee
Directors
|
200,000
|
300,000
|
400,000
|
480,000
|
|
Total
|
$
697,600
|
$
1,046,400
|
$
1,395,200
|
$
1,674,900
|
|
|
Three Months
Ended
|
Nine Months
Ended
|
||
|
|
October
31,
|
October
31
|
||
|
|
2019
|
2018
|
2019
|
2018
|
|
2017
Plan
|
$
(345
)
|
$
189
|
$
(596
)
|
$
491
|
|
Total stock-based
compensation
|
$
(345
)
|
$
189
|
$
(596
)
|
$
491
|
|
Shares issued
under
2017 Stock
Plan
|
Outstanding
Unvested Grants at Maximum at Beginning of FY20
|
Granted
during
FY20
|
Becoming Vested
during FY20
|
Forfeited
during
FY20
|
Outstanding
Unvested Grants at Maximum at End of
October 31,
2019
|
|
Restricted stock
grants – employees
|
84,126
|
-----
|
-----
|
12,397
|
71,729
|
|
Restricted stock
grants – non-employee directors
|
28,829
|
-----
|
-----
|
-----
|
28,829
|
|
Retainer in stock
– non-employee directors
|
25,044
|
7,292
|
2,675
|
-----
|
29,661
|
|
Total
restricted stock
|
137,999
|
7,292
|
2,675
|
12,397
|
130,219
|
|
|
|
|
|
|
|
|
Weighted average
grant date fair value
|
$
13.77
|
$
11.63
|
$
15.85
|
$
13.87
|
$
13.66
|
|
Stock
Options
|
Number of
Shares
|
Weighted Average
Exercise Price per Share
|
Weighted Average
Remaining Contractual Term (in years)
|
Aggregate
Intrinsic Value
|
|
Outstanding at July
31, 2019
|
-----
|
$
-----
|
-----
|
$
-----
|
|
Granted during the
quarter ended October 31, 2019
|
24,900
|
$
11.17
|
-----
|
-----
|
|
Outstanding at
October 31, 2019
|
24,900
|
$
11.17
|
9.79
|
-----
|
|
Exercisable at
October 31, 2019
|
-----
|
$
-----
|
-----
|
$
-----
|
|
|
FY20
|
|
|
|
|
Expected
volatility
|
53
%
|
|
Expected life in
years
|
10
|
|
Expected dividend
yield
|
0.00
%
|
|
Risk-free interest
rate
|
1.65
%
|
|
|
Three Months Ended
October 31, |
Nine Months Ended
October 31, |
||
|
|
(in $000s except share and per
share information)
|
|||
|
|
2019
|
2018
|
2019
|
2018
|
|
Numerator:
|
|
|
|
|
|
Net
income
|
$
1,146
|
$
501
|
$
2,076
|
$
3,386
|
|
Denominator:
|
|
|
|
|
|
Denominator for
basic earnings per share (weighted-average shares which reflect
shares in the treasury, 471,289 and 356,441 for October 31, 2019
and 2018, respectively)
|
8,004,640
|
8,119,448
|
8,013,383
|
8,117,307
|
|
Effect of dilutive
securities from restricted stock plan and from dilutive effect of
warrants
|
31,289
|
66,682
|
30,776
|
57,253
|
|
Denominator for
diluted earnings per share (adjusted weighted average
shares)
|
8,035,929
|
8,186,130
|
8,044,159
|
8,174,560
|
|
Basic earnings per
share
|
$
0.14
|
$
0.06
|
$
0.26
|
$
0.42
|
|
Diluted earnings
per share
|
$
0.14
|
$
0.06
|
$
0.26
|
$
0.41
|
|
Warrants,
restricted stock, and stock options excluded from the computation
of diluted earnings per share because the effect of inclusion would
have been anti-dilutive
|
125,457
|
|
|
|
|
|
Three Months
Ended
October
31,
|
Nine Months
Ended
October
31,
|
||||||
|
|
2019
|
2018
|
2019
|
2018
|
||||
|
|
|
|
|
|
|
|
|
|
|
Domestic
|
$
14.16
|
51.56
%
|
$
11.82
|
49.24
%
|
$
41.47
|
52.08
%
|
$
37.54
|
50.75
%
|
|
International
|
13.30
|
48.44
%
|
12.19
|
50.76
%
|
38.15
|
47.92
%
|
36.43
|
49.25
%
|
|
Total
|
$
27.46
|
100.00
%
|
$
24.01
|
100.00
%
|
$
79.62
|
100.00
%
|
$
73.97
|
100.00
%
|
|
|
Three Months
Ended
October
31,
(in millions of
dollars)
|
Nine Months
Ended
October
31,
(in millions of
dollars)
|
||
|
|
2019
|
2018
|
2019
|
2018
|
|
Net
Sales:
|
|
|
|
|
|
USA
|
$
15.84
|
$
13.00
|
$
45.36
|
$
41.07
|
|
Other
foreign
|
1.65
|
1.29
|
4.81
|
4.33
|
|
Europe
(UK)
|
2.38
|
2.22
|
7.24
|
7.35
|
|
Mexico
|
1.22
|
1.15
|
3.09
|
3.83
|
|
Asia
|
13.34
|
12.68
|
43.97
|
40.27
|
|
Canada
|
2.60
|
2.08
|
7.50
|
6.39
|
|
Latin
America
|
2.01
|
1.74
|
6.45
|
5.27
|
|
Corporate
|
-----
|
-----
|
-----
|
0.75
|
|
Less intersegment
sales
|
(11.58
)
|
(10.15
)
|
(38.80
)
|
(35.29
)
|
|
Consolidated
sales
|
$
27.46
|
$
24.01
|
$
79.62
|
$
73.97
|
|
External
Sales:
|
|
|
|
|
|
USA
|
$
14.16
|
$
11.82
|
$
41.47
|
$
37.54
|
|
Other
foreign
|
0.91
|
0.72
|
2.61
|
2.30
|
|
Europe
(UK)
|
2.38
|
2.22
|
7.24
|
7.35
|
|
Mexico
|
0.88
|
0.77
|
2.08
|
2.70
|
|
Asia
|
4.62
|
4.80
|
12.49
|
12.79
|
|
Canada
|
2.60
|
2.08
|
7.47
|
6.38
|
|
Latin
America
|
1.91
|
1.60
|
6.26
|
4.91
|
|
Consolidated
external sales
|
$
27.46
|
$
24.01
|
$
79.62
|
$
73.97
|
|
Intersegment
Sales:
|
|
|
|
|
|
USA
|
$
1.68
|
$
1.18
|
$
3.89
|
$
3.53
|
|
Other
foreign
|
0.74
|
0.57
|
2.20
|
2.02
|
|
Mexico
|
0.34
|
0.38
|
1.01
|
1.13
|
|
Asia
|
8.71
|
7.88
|
31.48
|
27.49
|
|
Canada
|
-----
|
-----
|
0.03
|
0.02
|
|
Latin
America
|
0.11
|
0.14
|
0.19
|
0.35
|
|
Corporate
|
-----
|
-----
|
-----
|
0.75
|
|
Consolidated
intersegment sales
|
$
11.58
|
$
10.15
|
$
38.80
|
$
35.29
|
|
|
Three Months
Ended
October
31,
(in millions of
dollars)
|
Nine Months
Ended
October
31,
(in millions of
dollars)
|
||
|
|
2019
|
2018
|
2019
|
2018
|
|
Operating Profit
:
|
|
|
|
|
|
USA
|
$
2.60
|
$
1.66
|
$
6.04
|
$
6.45
|
|
Other
foreign
|
0.14
|
0.02
|
0.30
|
0.23
|
|
Europe
(UK)
|
0.02
|
0.03
|
(0.02
)
|
0.21
|
|
Mexico
|
0.02
|
(0.03
)
|
(0.39
)
|
0.13
|
|
Asia
|
1.04
|
0.63
|
2.87
|
1.81
|
|
Canada
|
0.25
|
0.32
|
0.77
|
0.75
|
|
Latin
America
|
0.21
|
0.16
|
0.81
|
0.52
|
|
Corporate
|
(2.46
)
|
(1.61
)
|
(6.33
)
|
(4.96
)
|
|
Less intersegment
profit
|
0.01
|
(0.17
)
|
0.11
|
(0.06
)
|
|
Consolidated
operating profit
|
$
1.83
|
$
1.01
|
$
4.16
|
$
5.08
|
|
Depreciation and
Amortization Expense:
|
|
|
|
|
|
USA
|
$
0.04
|
$
0.03
|
$
0.21
|
$
0.09
|
|
Other
foreign
|
-----
|
-----
|
0.02
|
0.02
|
|
Europe
(UK)
|
-----
|
-----
|
-----
|
0.01
|
|
Mexico
|
0.04
|
0.03
|
0.12
|
0.09
|
|
Asia
|
0.14
|
0.04
|
0.40
|
0.19
|
|
Canada
|
0.03
|
0.02
|
0.08
|
0.05
|
|
Latin
America
|
0.01
|
0.01
|
0.03
|
0.03
|
|
Corporate
|
0.18
|
0.09
|
0.43
|
0.19
|
|
Less
intersegment
|
(0.01
)
|
-----
|
(0.02
)
|
(0.03
)
|
|
Consolidated
depreciation & amortization expense
|
$
0.43
|
$
0.22
|
$
1.27
|
$
0.64
|
|
Interest
Expense:
|
|
|
|
|
|
Europe
(UK)
|
$
-----
|
$
-----
|
$
0.01
|
$
----
|
|
Latin
America
|
0.01
|
0.01
|
0.04
|
0.03
|
|
Corporate
|
0.02
|
0.02
|
0.05
|
0.06
|
|
Consolidated
interest expense
|
$
0.03
|
$
0.03
|
$
0.10
|
$
0.09
|
|
Income Tax
Expense:
|
|
|
|
|
|
Europe
(UK)
|
$
0.01
|
$
0.01
|
$
0.01
|
0.05
|
|
Asia
|
0.16
|
0.29
|
0.67
|
0.80
|
|
Canada
|
0.10
|
0.02
|
0.32
|
0.17
|
|
Latin
America
|
-----
|
0.15
|
0.13
|
0.21
|
|
Corporate
|
0.38
|
0.05
|
0.81
|
0.39
|
|
Less
intersegment
|
-----
|
(0.03
)
|
0.01
|
0.01
|
|
Consolidated income
tax expense
|
$
0.65
|
$
0.49
|
$
1.95
|
$
1.63
|
|
Capital
Expenditures:
|
|
|
|
|
|
USA (including
Corporate)
|
$
(0.04
)
|
$
0.54
|
$
0.28
|
$
0.85
|
|
Other
foreign
|
0.01
|
0.36
|
0.02
|
1.13
|
|
Mexico
|
0.02
|
0.09
|
0.07
|
0.20
|
|
Asia
|
0.12
|
0.02
|
0.31
|
0.05
|
|
Latin
America
|
-----
|
-----
|
0.01
|
-----
|
|
Consolidated
capital expenditure
|
$
0.11
|
$
1.01
|
$
0.69
|
$
2.23
|
|
|
|
|
|
|
|
|
October
31,
2019
(in millions of
dollars)
|
January
31,
2019
(in millions of
dollars)
|
|
Total
Assets
|
|
|
|
USA
|
$
31.05
|
$
29.76
|
|
Other
foreign
|
3.57
|
2.85
|
|
Europe
(UK)
|
5.13
|
4.36
|
|
Mexico
|
5.45
|
5.13
|
|
Asia
|
23.31
|
20.97
|
|
Canada
|
6.00
|
6.64
|
|
Latin
America
|
5.46
|
5.27
|
|
Corporate
|
19.13
|
19.74
|
|
Consolidated
assets
|
$
99.10
|
$
94.72
|
|
Property and
Equipment
|
|
|
|
USA (including
Corporate)
|
$
3.55
|
$
3.87
|
|
Other
foreign
|
0.17
|
0.19
|
|
Europe
(UK)
|
-----
|
0.01
|
|
Mexico
|
2.10
|
2.14
|
|
Asia
|
3.10
|
3.17
|
|
Canada
|
1.18
|
1.26
|
|
Latin
America
|
0.05
|
0.07
|
|
Less
intersegment
|
0.08
|
0.07
|
|
Consolidated
property and equipment
|
$
10.23
|
$
10.78
|
|
Goodwill:
|
|
|
|
USA
|
$
0.87
|
$
0.87
|
|
Consolidated
goodwill
|
$
0.87
|
$
0.87
|
|
|
Three Months Ended
October 31,
(in millions of dollars)
|
Nine Months Ended
October
31,
(in millions of dollars)
|
||
|
|
2019
|
2018
|
2019
|
2018
|
|
External
Sales by geographic region:
|
|
|
|
|
|
USA
|
$
14.16
|
$
11.82
|
$
41.47
|
$
37.54
|
|
Other
foreign
|
0.91
|
0.72
|
2.61
|
2.30
|
|
Europe
(UK)
|
2.38
|
2.22
|
7.24
|
7.35
|
|
Mexico
|
0.88
|
0.77
|
2.08
|
2.70
|
|
Asia
|
4.62
|
4.80
|
12.49
|
12.79
|
|
Canada
|
2.60
|
2.08
|
7.47
|
6.38
|
|
Latin
America
|
1.91
|
1.60
|
6.26
|
4.91
|
|
Consolidated
external sales
|
$
27.46
|
$
24.01
|
$
79.62
|
$
73.97
|
|
|
Three Months Ended
October 31,
(in millions of dollars)
|
Nine Months Ended
October
31,
(in millions of dollars)
|
||
|
|
2019
|
2018
|
2019
|
2018
|
|
External
Sales by product lines:
|
|
|
|
|
|
Disposables
|
$
12.52
|
$
12.74
|
$
39.19
|
$
40.88
|
|
Chemical
|
5.68
|
4.74
|
16.30
|
12.42
|
|
Fire
|
2.81
|
1.02
|
6.64
|
3.57
|
|
Gloves
|
0.74
|
0.77
|
2.33
|
2.30
|
|
Hi-Vis
|
2.20
|
1.83
|
6.04
|
5.46
|
|
Wovens
|
3.51
|
2.91
|
9.12
|
9.34
|
|
Consolidated
external sales
|
$
27.46
|
$
24.01
|
$
79.62
|
$
73.97
|
|
31.1
*
|
Certification
of Chief Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a)
under the Securities Exchange Act of 1934
|
|
31.2
*
|
Certification
of Principal Financial Officer pursuant to Rule 13a-14(a) or
15d-14(a) under the Securities Exchange Act of 1934
|
|
32.1
*
|
Certification
of Chief Executive Officer as adopted pursuant to Rule 13a-14(a)
pursuant to Section 906 of the Sarbanes-Oxley Act of
2002
|
|
32.2
*
|
Certification
of Principal Financial Officer as adopted pursuant to 18 U.S.C.
Section 1350 pursuant to Section 906 of the Sarbanes-Oxley Act of
2002
|
|
101.INS
|
XBRL
instance Document
|
|
101.SCH
|
XBRL
Taxonomy Extension Schema Document
|
|
101.CAL
|
XBRL
Taxonomy Extension Definitions Document
|
|
101.DEF
|
XBRL
Taxonomy Extension Labels Document
|
|
101.LAB
|
XBRL
Taxonomy Extension Labels Document
|
|
101.PRE
|
XBRL
Taxonomy Extension Presentations Document
|
|
|
LAKELAND INDUSTRIES, INC.
(Registrant)
|
|
|
|
|
|
|
|
Date:
December 9, 2019
|
/s/ Christopher J. Ryan
|
|
|
Christopher
J. Ryan,
Chief
Executive Officer, President and Secretary (Principal Executive
Officer and Authorized Signatory)
|
|
|
|
|
|
|
|
Date:
December 9, 2019
|
/s/ Allen E. Dillard
|
|
|
Allen
E. Dillard,
(Principal
Financial Officer and Authorized Signatory)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|